Simeon A. Lauer, MD
Figure 1. Microcystic adnexal carcinoma. Image courtesy Mark J. Lucarelli, MD.
Figure 2. Microcystic adnexal carcinoma pathology. Image courtesy Mark J. Lucarelli, MD.
Microcystic adnexal carcinoma has been reported to arise in the context of immunosuppression and prior radiotherapy.
Morbidity for these tumors is related to the extent of tumor involvement, the need for surgical excision and effects of radiotherapy when used.
In the SEER database analysis described above for MAC the overall 10 year survival was 86%.
Microcystic adnexal carcinoma was first described by Goldstein in 1982 (Goldstein, Cancer 1982).